Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liquiritigenin, also known as 5-deoxyflavanone, is a naturally occurring flavanone found primarily in the roots of Glycyrrhiza species (such as licorice). It is characterized by hydroxy groups at the 4' and 7 positions on its flavanone backbone. Liquiritigenin acts as a selective agonist for Estrogen receptor beta (ERβ), distinguishing it from other estrogens that may also activate Estrogen receptor alpha (ERα). This selectivity has led to interest in its use for menopausal symptoms such as hot flashes and night sweats. Additionally, liquiritigenin exhibits inhibitory activity against Xanthine dehydrogenase/oxidase and has demonstrated antitumor and cytoprotective effects against oxidative stress in preclinical studies[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Liquiritigenin.